...
search icon
dmra-img

Damora Therapeutics, Inc. Share Price

DMRA
NAQ
$23.05
+$4.91
(27.07%)
1D

Damora Therapeutics, Inc. Analyst Forecast

Damora Therapeutics, Inc. Share Price Chart

Damora Therapeutics, Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.09B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
337.88K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.01 L
$38.33 H
$23.05

About Damora Therapeutics, Inc., Common Stock

Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark. more

Damora Therapeutics, Inc. Stock Returns

Data is not properly formatted.

Damora Therapeutics, Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue188.00K441.00K490.00K830.00K181.00K[{"date":"2020-12-31","value":22.65,"profit":true},{"date":"2021-12-31","value":53.13,"profit":true},{"date":"2022-12-31","value":59.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":21.81,"profit":true}]
Gross Profit(188.00K)(441.00K)(490.00K)(830.00K)(181.00K)[{"date":"2020-12-31","value":-18800000,"profit":false},{"date":"2021-12-31","value":-44100000,"profit":false},{"date":"2022-12-31","value":-49000000,"profit":false},{"date":"2023-12-31","value":-83000000,"profit":false},{"date":"2024-12-31","value":-18100000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses33.45M51.79M60.72M35.63M16.72M[{"date":"2020-12-31","value":55.09,"profit":true},{"date":"2021-12-31","value":85.29,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":58.68,"profit":true},{"date":"2024-12-31","value":27.53,"profit":true}]
Operating Income(33.64M)(52.23M)(61.21M)(36.46M)(16.90M)[{"date":"2020-12-31","value":-3363700000,"profit":false},{"date":"2021-12-31","value":-5222700000,"profit":false},{"date":"2022-12-31","value":-6120700000,"profit":false},{"date":"2023-12-31","value":-3645700000,"profit":false},{"date":"2024-12-31","value":-1689700000,"profit":false}]
Total Non-Operating Income/Expense-631.00K305.00K(203.00K)(3.66M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":48.34,"profit":true},{"date":"2023-12-31","value":-32.17,"profit":false},{"date":"2024-12-31","value":-579.56,"profit":false}]
Pre-Tax Income(34.84M)(51.75M)(61.62M)(38.35M)(21.40M)[{"date":"2020-12-31","value":-3483700000,"profit":false},{"date":"2021-12-31","value":-5175200000,"profit":false},{"date":"2022-12-31","value":-6162400000,"profit":false},{"date":"2023-12-31","value":-3834900000,"profit":false},{"date":"2024-12-31","value":-2139800000,"profit":false}]
Income Taxes----41.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes----(21.44M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-2143900000,"profit":false}]
Income From Continuous Operations-(51.75M)(61.62M)(38.35M)(21.44M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-5175200000,"profit":false},{"date":"2022-12-31","value":-6162400000,"profit":false},{"date":"2023-12-31","value":-3834900000,"profit":false},{"date":"2024-12-31","value":-2143900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(34.84M)(51.75M)(61.62M)(38.35M)(21.44M)[{"date":"2020-12-31","value":-3483700000,"profit":false},{"date":"2021-12-31","value":-5175200000,"profit":false},{"date":"2022-12-31","value":-6162400000,"profit":false},{"date":"2023-12-31","value":-3834900000,"profit":false},{"date":"2024-12-31","value":-2143900000,"profit":false}]
EPS (Diluted)(18.10)(51.22)(60.65)(36.31)(18.59)[{"date":"2020-12-31","value":-1810.4,"profit":false},{"date":"2021-12-31","value":-5121.56,"profit":false},{"date":"2022-12-31","value":-6065.27,"profit":false},{"date":"2023-12-31","value":-3631.2,"profit":false},{"date":"2024-12-31","value":-1858.73,"profit":false}]

Damora Therapeutics, Inc. Ratios

Damora Therapeutics, Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

DMRA
Cash Ratio 2.90
Current Ratio 3.73

Damora Therapeutics, Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DMRA
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Damora Therapeutics, Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DMRA
Debt Ratio Lower is generally better. Negative is bad. 0.38
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.62

Damora Therapeutics, Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DMRA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 173.60
EV/R 0.00
EV/Ebitda 0.46

FAQs

What is Damora Therapeutics, Inc. share price today?

Damora Therapeutics, Inc. (DMRA) share price today is $23.05

Can Indians buy Damora Therapeutics, Inc. shares?

Yes, Indians can buy shares of Damora Therapeutics, Inc. (DMRA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DMRA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Damora Therapeutics, Inc. be purchased?

Yes, you can purchase fractional shares of Damora Therapeutics, Inc. (DMRA) via the Vested app. You can start investing in Damora Therapeutics, Inc. (DMRA) with a minimum investment of $1.

How to invest in Damora Therapeutics, Inc. shares from India?

You can invest in shares of Damora Therapeutics, Inc. (DMRA) via Vested in three simple steps:

  • Click on Sign Up or Invest in DMRA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Damora Therapeutics, Inc. shares
What is Damora Therapeutics, Inc. 52-week high and low stock price?

The 52-week high price of Damora Therapeutics, Inc. (DMRA) is $38.33. The 52-week low price of Damora Therapeutics, Inc. (DMRA) is $2.01.

What is Damora Therapeutics, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Damora Therapeutics, Inc. (DMRA) is

What is Damora Therapeutics, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Damora Therapeutics, Inc. (DMRA) is 173.60

What is Damora Therapeutics, Inc. dividend yield?

The dividend yield of Damora Therapeutics, Inc. (DMRA) is 0.00%

What is the Market Cap of Damora Therapeutics, Inc.?

The market capitalization of Damora Therapeutics, Inc. (DMRA) is $1.09B

What is Damora Therapeutics, Inc.'s stock symbol?

The stock symbol (or ticker) of Damora Therapeutics, Inc. is DMRA

How Can Investors Use Damora Therapeutics, Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Damora Therapeutics, Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Damora Therapeutics, Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Damora Therapeutics, Inc. shares for Indian investors?

When investing in Damora Therapeutics, Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Damora Therapeutics, Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Damora Therapeutics, Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Damora Therapeutics, Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Damora Therapeutics, Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top